After World War II, the anti-infective drug Gantrisin developed by the company became one of the most widely used prescription drugs. From 1950s to 1960s, the company promoted development by vigorously expanding foreign markets and accelerating research and development. The sedative hypnotic and valine introduced by the company in the early 1960s made the company famous. In 1970s, he was fined for participating in vitamin monopoly. In addition, since the 1930s, the company has continued to diversify. During this period, the company increased the production of vitamins and perfumes. 1April, 1984, the company implemented a structural reorganization plan to reduce production costs and increase market share. In June of the same year, Roferon developed by the company was approved for sale by the US Food and Drug Administration, which became a milestone in the company's history.
1987, Roach Holdings was incorporated in the United States. 1989, the company sold Rotron Electronics to BMW and established Roach Holdings Limited. From 65438 to 0990, the company spent more than $2 billion to buy a 60% stake in Genentech, which caused a sensation and marked the company's entry into the field of biotechnology. 199 1, the company acquired Nicola Laboratories, thus occupying a larger share in the OTC market in Europe.
In the second half of 1990s, the company made further large-scale mergers and introduced new products at a faster speed. For example, 1997 acquired Corange Company, and 1999 wholly acquired Genentech Company. In terms of new drugs, such as Roxifene, Antonymine, Flutielong, Yipin Su, Madopar, Rogaiquan, Luo Naijin, Xiaoxi, etc. Some new drugs, such as Seneco, Xeloda, Herceptin and Tamiflu, are in the planning stage.